1999
DOI: 10.1016/s0300-483x(98)00143-7
|View full text |Cite
|
Sign up to set email alerts
|

Increase by NO synthase inhibitor of lead-induced release of N-acetyl-β-d-glucosaminidase from perfused rat kidney

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
4
0

Year Published

2002
2002
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 13 publications
(5 citation statements)
references
References 30 publications
1
4
0
Order By: Relevance
“…Dehpour et al in 1999 have shown significant increase in NAG level with LA administration. 26 similar results are seen in the present study, that LA administrated groups showed a significant increase in NAG level indicating nephrotoxicity occurrence. Lead produce its deleterious effect by attributed its ability to induce oxidative injury by generate ROS in the kidney by two separate, although related, pathways.…”
Section: Discussionsupporting
confidence: 93%
“…Dehpour et al in 1999 have shown significant increase in NAG level with LA administration. 26 similar results are seen in the present study, that LA administrated groups showed a significant increase in NAG level indicating nephrotoxicity occurrence. Lead produce its deleterious effect by attributed its ability to induce oxidative injury by generate ROS in the kidney by two separate, although related, pathways.…”
Section: Discussionsupporting
confidence: 93%
“…NAG is a sensitive hydrolytic lysosomal enzyme that is released after renal tubular damage [26]. In the rat, urinary NAG is a useful early marker of renal injury induced by acetaminophen, aspirin, lead, and gentamicin [30][31][32]. In our previous clinical protocol, we successfully implemented ion supplementation, as well as vigorous hydration of patients, as nephroprotective measures to prevent AmB-induced acute decrease in renal function [25].…”
Section: Discussionmentioning
confidence: 99%
“…α, β and γ Ig [20,21], serum alanin aminotransferase (ALT), aspartate aminotransferase (AST) activities [22], serum alkaline phosphatase, (ALP) activity (kits of bioMerieux/ France) [23], serum urea level (kits bioMerieux) [24], serum creatinine (kits bioMerieux) [25], serum cholesterol [26] and Lipid peroxidation (LPO) (kits (Biodiaguostic) ® ) [27] were determined. Serum Lead level was estimated using an atomic absorption spectrophotometer/flame [28]. The concentrations of T3 and T4 were assayed according to the method described by Nussey and Whitehead [29] using enzymelinked immunosorbent assay (ELISA) kits (Microwell T3, T4 kits; Synthron Bioresearch, Inc, USA).…”
Section: Serum Biochemical Analysismentioning
confidence: 99%